Zhan Hao, Song Ying, Stephanie Wu, Lv Hongjie
China’s competition watchdog SAMR made a penalty decision, adopted by its Shanghai branch Shanghai Market Regulation Bureau (“SMRB”), publicized on its official website[1] on April 29, 2019, right before the International Labor Day holiday. This decision is addressed to Eastman (China) Investment Management Co., Ltd. (“Eastman China”), a Chinese subsidiary of the US Chemical firm Eastman Chemical Company, for restricting transactions by abusing its dominant market position. The fine amount is equal to 5% of Eastman China’s 2016 sales revenue, roughly USD 3.6 million.
Authored by Zhan Hao <zhanhao@anjielaw.com> , Song Ying <songying@anjielaw.com>, Wu Yuanyuan <wuyuanyuan@anjielaw.com> , Lv Hongjie <lvhongjie@anjielaw.com>at AnJie Law Firm